Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Other Working Capital Changes (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Other Working Capital Changes for 6 consecutive years, with $1.0 million as the latest value for Q4 2021.

  • Quarterly Other Working Capital Changes rose 221.0% to $1.0 million in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $957203.0 through Dec 2021, up 867.51% year-over-year, with the annual reading at -$89252.0 for FY2025, 65.12% up from the prior year.
  • Other Working Capital Changes for Q4 2021 was $1.0 million at ENDRA Life Sciences, up from $507834.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $1.0 million in Q4 2021, with the low at -$1.2 million in Q2 2020.
  • Average Other Working Capital Changes over 5 years is $63284.6, with a median of $7090.5 recorded in 2017.
  • The sharpest move saw Other Working Capital Changes skyrocketed 32734.11% in 2018, then plummeted 1002.28% in 2020.
  • Over 5 years, Other Working Capital Changes stood at $65610.0 in 2017, then plummeted by 102.26% to -$1484.0 in 2018, then soared by 3159.84% to $45408.0 in 2019, then skyrocketed by 604.92% to $320090.0 in 2020, then surged by 221.0% to $1.0 million in 2021.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $1.0 million, $507834.0, and -$561255.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.